Liposonix is a body contouring system that involves the use of high intensity ultrasound technology to reduce subcutaneous abdominal fat. Clinical trials have demonstrated the effectiveness of the system, which takes approximately one hour to administer and requires little down time for the patient,beats by dr. Liposonix is currently being offered to patients in Canada and parts of Europe, but is not yet approved for use in the United States due to the lack of approval by the Food and Drug Administration (FDA),christian louboutin france.

Development of this system was initiated by Liposonix,louboutin sale uk, Inc. in 2001. Liposonix, Inc. was ultimately acquired by Medicis Technologies Corporation, with corporate headquarters in Bothell, Washington,pourrais-je trouver une station-service. In 2008, Medicis Technologies Corporation began operating as a subsidiary of the Medicis Pharmaceutical Corporation. The focus of the corporation is the development of body sculpting techniques.

The Liposonix system operates by delivering energy to adipose tissue through the use of a high intensity ultrasound transducer. Underlying fat cells are emulsified as the ultrasound waves are transmitted through the skin. The broken down fat cells are then carried away by macrophages. The process is non-invasive and is designed to avoid harm to the epidermis or internal organs. The ultimate goals of Liposonix are fat loss and a reduction in the appearance of cellulite.


Unlike more invasive treatments such as liposuction procedures,cheap north face,Weight Loss Fast - Sos, the recovery and down time for Liposonix treatments is minimal for the patient and the treatment can be completed in approximately one hour. Patients receiving a Liposonix treatment may feel some discomfort or a prickling sensation during the process.

This procedure is not recommended for use with pregnant women nor in patients with cancer. The system is also not designed for use in patients with a BMI greater than 30, or in patients with an implanted electrical device. Liposonix facts should be carefully reviewed prior to receipt of treatment.

While the Liposonix system is CE marked and compliant with European Union directives, it is not yet approved for use in the United States by the FDA. Clinical trials in the United States are currently in process and it is possible that the technology could be approved for use in the United States in 2011,Tips to Correct 'Incorrect block count for file' Error in Mac OS X,beats by dre.